Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2

被引：56
|
作者：
Chen, Sha [1 ]
Wang, Qian [1 ]
Christodoulou, Andriana [4 ]
Mylonas, Nikolaos [4 ]
Bakker, Diane [1 ]
Nederlof, Rianne [5 ,6 ]
Hollmann, Markus W. [1 ]
Weber, Nina C. [1 ]
Coronel, Ruben [2 ]
Wakker, Vincent [3 ]
Christoffels, Vincent M. [3 ]
Andreadou, Ioanna [4 ]
Zuurbier, Coert J. [1 ]
机构：
[1] Univ Amsterdam, Lab Expt Intens Care & Anesthesiol, Dept Anesthesiol, Amsterdam UMC,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[2] Univ Amsterdam, Dept Expt Cardiol, Amsterdam UMC, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Med Biol, Amsterdam UMC, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[4] Natl & Kapodistrian Univ Athens, Pharmacol Lab, Fac Pharm, Athens, Greece
[5] Heinrich Heine Univ Dusseldorf, Med Fak, Inst Herz & Kreislaufphysiol, Dusseldorf, Germany
[6] Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Dusseldorf, Germany
来源：
CIRCULATION | 2023年 / 147卷 / 03期
关键词：
body weight; empagliflozin; glucose; infarct size; ischemia; reperfusion; ketones; sodium-glucose cotransporter 2 inhibitor;
D O I：
10.1161/CIRCULATIONAHA.122.061688
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：276 / 279
页数：4
相关论文
共 50 条
  • [31] Association of sodium-glucose cotransporter-2 inhibitor with regression of coronary plaque burden
    Zhang, T.
    Du, Y.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [32] Sodium-Glucose Cotransporter-2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
    Porcari, Aldostefano
    Cappelli, Francesco
    Nitsche, Christian
    Tomasoni, Daniela
    Sinigiani, Giulio
    Longhi, Simone
    Bordignon, Luca
    Masri, Ahmad
    Serenelli, Matteo
    Urey, Marcus A.
    Musumeci, Beatrice
    Cipriani, Alberto
    Canepa, Marco
    Eslam, Roza Badr
    Kronberger, Christina
    Chimenti, Cristina
    Zampieri, Mattia
    Allegro, Valentina
    Razvi, Yousuf
    Patel, Rishi
    Ioannou, Adam
    Rauf, Muhammad U.
    Petrie, Aviva
    Whelan, Carol
    Emdin, Michele
    Metra, Marco
    Merlo, Marco
    Sinagra, Gianfranco
    Hawkins, Philip
    Solomon, Scott
    Gillmore, Julian
    Fontana, Marianna
    CIRCULATION, 2023, 148 (25) : E303 - E303
  • [33] Association of sodium-glucose cotransporter-2 inhibitor with regression of coronary plaque burden
    Zhang, T.
    Du, Y.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Sodium-glucose cotransporter-2 inhibitors reduce risk of nephrolithiasis
    Di Lellis, Maddalena Angela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (12) : 674 - 675
  • [35] Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives
    Mondal, Sunetra
    Pramanik, Subhodip
    Khare, Vibhu Ranjan
    Fernandez, Cornelius James
    Pappachan, Joseph M.
    WORLD JOURNAL OF CARDIOLOGY, 2024, 16 (05): : 240 - 259
  • [36] Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
    Yang Fan
    Meng Ran
    Zhu Da-Long
    慢性疾病与转化医学（英文）, 2020, 06 (04) : 239 - 245
  • [37] Expanding Clinical Use of Sodium-glucose Cotransporter-2 Inhibitors?
    Dhawan, Richa
    Chaney, Mark A.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (10) : 2135 - 2138
  • [38] Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections
    Sarafidis, Pantelis
    Papagianni, Aikaterini
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (12) : 943 - 944
  • [39] Sodium-glucose cotransporter-2 inhibitors in patients without diabetes
    Fryml, Elise
    Lanktree, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (17) : E619 - E619
  • [40] Sodium-glucose cotransporter-2 inhibitors reduce the risk of gout
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (02): : 190 - 191
12345